On the afternoon of the 18th, President Moon Jae-in visited Poonglim Pharmatech, the production site of the LDS vaccine syringe production site for new coronavirus infection (Corona 19) vaccination in Gunsan, Jeollabuk-do, and inspects the production line of the LDS vaccine syringe. Gunsan = Newsis
Mihee Cho, Vice President of Poonglim Pharmatech, which is known as a’fresh syringe’ for vaccination against the novel coronavirus infection (Corona 19), has attracted great interest worldwide Revealed.
Vice President Cho appeared on TBS Radio’Kim Eo-Jun’s News Factory’ on the 19th and said, “I participated in the project as a means to speed up the introduction of the (Corona 19 vaccine) required by the government.” I thought to distribute it first,” he said.
Poonglim Pharmatech is a successful company by challenging the production of minimal residual type (LDS) syringes to overcome Corona 19. On the 18th, President Moon Jae-in visited the headquarters of Poonglim Pharmatech in Gunsan, Jeollabuk-do, and it became a hot topic.
This company’s product is currently called a’squeeze syringe’, and it minimizes the amount of vaccine left in the syringe when the drug is administered. It was recently approved for use by the US Food and Drug Administration (FDA).
Existing syringes have to be used for inoculation of only 5 people even if 6 vaccines are put in, but the remaining 1 (20%) should be discarded, but Poonglim Pharmatech’s syringes can inoculate 6 people without discarding the amount. Therefore, when using this syringe for vaccination, it is known that it has the effect of increasing the production of the vaccine by an additional 20%, and it is receiving purchase requests in more than 20 countries around the world.
Vice President Cho said, “The reason why drugs cannot be used immediately even if they are developed is because of safety.” At the same time, he introduced, “Because there are no products that reduce the remaining amount of vaccines and have safety devices around the world, (Punglim Pharmatech) seems to be attracting attention.”
180 million short-term supply contract with Pfizer
President Moon Jae-in is speaking at an on-site meeting held at Poonglim Pharmatech, a facility for producing LDS syringes for new coronavirus infection (Corona 19) vaccination in Gunsan, Jeollabuk-do on the afternoon of the 18th. Gunsan = Yonhap News
Vice President Cho cited’win-win with Samsung’ as the secret to gaining great attention worldwide. He said, “At the beginning, a collaboration proposal came from Samsung, and the SME venture department played a (connecting) role, so we could find a point where we can coexist,” he said. “Samsung is working together with the licensing part, data inspection, and product mass production.” He emphasized.
Vice President Jo said he was also worried about joining hands with large companies.
He said, “I was afraid that the corporate culture that we had maintained in our own way would change if we get the help of a large company, and that technology would not be leaked,” he said. “But, of course, when the nation said it was necessary because I had a belief in the localization of medical devices. I thought I had to participate.”
Vice President Cho said, “As a Korean company, I think we should allocate (the necessary amount) to our country first.” “(Corona 19 vaccine) 120,000 Pfizer vaccines are coming in now, and 120,000 (syringes) are willing to donate. “He added.
Son Hyo-suk reporter [email protected]
News directly edited by the Hankook Ilbo can also be viewed on Naver.
